25 XP   0   0   10

Tibet Rhodiola Pharmaceutical Holding Co
Buy, Hold or Sell?

Let's analyse Tibet Rhodiola Pharmaceutical Holding Co together

PenkeI guess you are interested in Tibet Rhodiola Pharmaceutical Holding Co. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Tibet Rhodiola Pharmaceutical Holding Co. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Tibet Rhodiola Pharmaceutical Holding Co

I send you an email if I find something interesting about Tibet Rhodiola Pharmaceutical Holding Co.

Quick analysis of Tibet Rhodiola Pharmaceutical Holding Co (30 sec.)










What can you expect buying and holding a share of Tibet Rhodiola Pharmaceutical Holding Co? (30 sec.)

How much money do you get?

How much money do you get?
¥0.38
When do you have the money?
1 year
How often do you get paid?
92.5%

What is your share worth?

Current worth
¥13.61
Expected worth in 1 year
¥14.99
How sure are you?
92.5%

+ What do you gain per year?

Total Gains per Share
¥4.12
Return On Investment
8.9%

For what price can you sell your share?

Current Price per Share
¥46.28
Expected price per share
¥35.60 - ¥49.61
How sure are you?
50%

1. Valuation of Tibet Rhodiola Pharmaceutical Holding Co (5 min.)




Live pricePrice per Share (EOD)

¥46.28

Intrinsic Value Per Share

¥50.78 - ¥60.17

Total Value Per Share

¥64.38 - ¥73.77

2. Growth of Tibet Rhodiola Pharmaceutical Holding Co (5 min.)




Is Tibet Rhodiola Pharmaceutical Holding Co growing?

Current yearPrevious yearGrowGrow %
How rich?$466.2m$409.5m$62.8m13.3%

How much money is Tibet Rhodiola Pharmaceutical Holding Co making?

Current yearPrevious yearGrowGrow %
Making money$27.6m$12.7m$14.8m53.8%
Net Profit Margin26.4%14.1%--

How much money comes from the company's main activities?

3. Financial Health of Tibet Rhodiola Pharmaceutical Holding Co (5 min.)




What can you expect buying and holding a share of Tibet Rhodiola Pharmaceutical Holding Co? (5 min.)

Welcome investor! Tibet Rhodiola Pharmaceutical Holding Co's management wants to use your money to grow the business. In return you get a share of Tibet Rhodiola Pharmaceutical Holding Co.

What can you expect buying and holding a share of Tibet Rhodiola Pharmaceutical Holding Co?

First you should know what it really means to hold a share of Tibet Rhodiola Pharmaceutical Holding Co. And how you can make/lose money.

Speculation

The Price per Share of Tibet Rhodiola Pharmaceutical Holding Co is ¥46.28. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Tibet Rhodiola Pharmaceutical Holding Co.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Tibet Rhodiola Pharmaceutical Holding Co, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥13.61. Based on the TTM, the Book Value Change Per Share is ¥0.35 per quarter. Based on the YOY, the Book Value Change Per Share is ¥0.39 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.68 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Tibet Rhodiola Pharmaceutical Holding Co.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps-0.03-0.1%0.110.2%0.050.1%0.060.1%0.040.1%
Usd Book Value Change Per Share-0.04-0.1%0.050.1%0.050.1%0.030.1%0.040.1%
Usd Dividend Per Share0.000.0%0.090.2%0.010.0%0.040.1%0.030.1%
Usd Total Gains Per Share-0.04-0.1%0.140.3%0.070.1%0.070.2%0.070.1%
Usd Price Per Share6.74-7.31-5.34-6.65-6.06-
Price to Earnings Ratio-55.58--4.94-5.33-16.08-63.46-
Price-to-Total Gains Ratio-173.20--13.11-20.05-92.39-1,162.78-
Price to Book Ratio3.59-3.83-3.25-4.30-9.67-
Price-to-Total Gains Ratio-173.20--13.11-20.05-92.39-1,162.78-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share6.395896
Number of shares156
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.090.04
Usd Book Value Change Per Share0.050.03
Usd Total Gains Per Share0.140.07
Gains per Quarter (156 shares)22.1911.03
Gains per Year (156 shares)88.7744.11
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1593079251934
211860168493978
3177892577458122
42361193469978166
529514943512397210
6354179524148116254
7413209613173136298
8472238702198155342
9531268791222175386
10590298880247194430

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share3.01.00.075.0%9.03.00.075.0%17.03.00.085.0%35.04.01.087.5%75.04.09.085.2%
Book Value Change Per Share2.02.00.050.0%7.05.00.058.3%13.07.00.065.0%31.09.00.077.5%69.019.00.078.4%
Dividend per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%37.00.03.092.5%67.00.021.076.1%
Total Gains per Share3.01.00.075.0%9.03.00.075.0%17.03.00.085.0%37.03.00.092.5%79.09.00.089.8%

Fundamentals of Tibet Rhodiola Pharmaceutical Holding Co

About Tibet Rhodiola Pharmaceutical Holding Co

Tibet Rhodiola Pharmaceutical Holding Co. engages in the research and development, production, and sale of pharmaceuticals in China and internationally. It offers biological products, Tibetan medicine, Chinese medicine, and chemical medicine products. The company was founded in 1999 and is based in Lhasa, China.

Fundamental data was last updated by Penke on 2024-04-17 05:59:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is cheap.

1.1. Profitability of Tibet Rhodiola Pharmaceutical Holding Co.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Tibet Rhodiola Pharmaceutical Holding Co earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Tibet Rhodiola Pharmaceutical Holding Co to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of -7.1% means that ¥-0.07 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Tibet Rhodiola Pharmaceutical Holding Co:

  • The MRQ is -7.1%. The company is making a loss. -1
  • The TTM is 26.4%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ-7.1%TTM26.4%-33.5%
TTM26.4%YOY14.1%+12.3%
TTM26.4%5Y21.5%+4.9%
5Y21.5%10Y18.8%+2.7%
1.1.2. Return on Assets

Shows how efficient Tibet Rhodiola Pharmaceutical Holding Co is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Tibet Rhodiola Pharmaceutical Holding Co to the Drug Manufacturers - Specialty & Generic industry mean.
  • -1.2% Return on Assets means that Tibet Rhodiola Pharmaceutical Holding Co generated ¥-0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Tibet Rhodiola Pharmaceutical Holding Co:

  • The MRQ is -1.2%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is 4.2%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ-1.2%TTM4.2%-5.4%
TTM4.2%YOY2.2%+2.0%
TTM4.2%5Y2.9%+1.3%
5Y2.9%10Y2.6%+0.4%
1.1.3. Return on Equity

Shows how efficient Tibet Rhodiola Pharmaceutical Holding Co is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Tibet Rhodiola Pharmaceutical Holding Co to the Drug Manufacturers - Specialty & Generic industry mean.
  • -1.6% Return on Equity means Tibet Rhodiola Pharmaceutical Holding Co generated ¥-0.02 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Tibet Rhodiola Pharmaceutical Holding Co:

  • The MRQ is -1.6%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is 5.9%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ-1.6%TTM5.9%-7.5%
TTM5.9%YOY3.2%+2.7%
TTM5.9%5Y3.7%+2.2%
5Y3.7%10Y4.0%-0.4%

1.2. Operating Efficiency of Tibet Rhodiola Pharmaceutical Holding Co.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Tibet Rhodiola Pharmaceutical Holding Co is operating .

  • Measures how much profit Tibet Rhodiola Pharmaceutical Holding Co makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Tibet Rhodiola Pharmaceutical Holding Co to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated ¥0.00  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Tibet Rhodiola Pharmaceutical Holding Co:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM8.7%-8.7%
TTM8.7%YOY27.0%-18.3%
TTM8.7%5Y24.3%-15.6%
5Y24.3%10Y14.0%+10.3%
1.2.2. Operating Ratio

Measures how efficient Tibet Rhodiola Pharmaceutical Holding Co is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 0.66 means that the operating costs are ¥0.66 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Tibet Rhodiola Pharmaceutical Holding Co:

  • The MRQ is 0.657. The company is efficient in keeping operating costs low. +1
  • The TTM is 0.646. The company is efficient in keeping operating costs low. +1
Trends
Current periodCompared to+/- 
MRQ0.657TTM0.646+0.010
TTM0.646YOY0.762-0.116
TTM0.6465Y0.787-0.140
5Y0.78710Y0.639+0.148

1.3. Liquidity of Tibet Rhodiola Pharmaceutical Holding Co.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Tibet Rhodiola Pharmaceutical Holding Co is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 2.87 means the company has ¥2.87 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Tibet Rhodiola Pharmaceutical Holding Co:

  • The MRQ is 2.873. The company is able to pay all its short-term debts. +1
  • The TTM is 2.715. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.873TTM2.715+0.158
TTM2.715YOY2.340+0.375
TTM2.7155Y3.163-0.448
5Y3.16310Y1.876+1.287
1.3.2. Quick Ratio

Measures if Tibet Rhodiola Pharmaceutical Holding Co is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Tibet Rhodiola Pharmaceutical Holding Co to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.98 means the company can pay off ¥0.98 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Tibet Rhodiola Pharmaceutical Holding Co:

  • The MRQ is 0.985. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 1.139. The company is just able to pay all its short-term debts with the most liquid assets.
Trends
Current periodCompared to+/- 
MRQ0.985TTM1.139-0.154
TTM1.139YOY1.211-0.072
TTM1.1395Y1.276-0.137
5Y1.27610Y0.963+0.313

1.4. Solvency of Tibet Rhodiola Pharmaceutical Holding Co.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Tibet Rhodiola Pharmaceutical Holding Co assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Tibet Rhodiola Pharmaceutical Holding Co to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.26 means that Tibet Rhodiola Pharmaceutical Holding Co assets are financed with 26.5% credit (debt) and the remaining percentage (100% - 26.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Tibet Rhodiola Pharmaceutical Holding Co:

  • The MRQ is 0.265. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.273. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.265TTM0.273-0.009
TTM0.273YOY0.282-0.009
TTM0.2735Y0.202+0.071
5Y0.20210Y0.321-0.119
1.4.2. Debt to Equity Ratio

Measures if Tibet Rhodiola Pharmaceutical Holding Co is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Tibet Rhodiola Pharmaceutical Holding Co to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 36.3% means that company has ¥0.36 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Tibet Rhodiola Pharmaceutical Holding Co:

  • The MRQ is 0.363. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.379. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.363TTM0.379-0.016
TTM0.379YOY0.396-0.017
TTM0.3795Y0.267+0.112
5Y0.26710Y0.715-0.448

2. Market Valuation of Tibet Rhodiola Pharmaceutical Holding Co

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Tibet Rhodiola Pharmaceutical Holding Co generates.

  • Above 15 is considered overpriced but always compare Tibet Rhodiola Pharmaceutical Holding Co to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of -55.58 means the investor is paying ¥-55.58 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Tibet Rhodiola Pharmaceutical Holding Co:

  • The EOD is -52.705. Based on the earnings, the company is expensive. -2
  • The MRQ is -55.575. Based on the earnings, the company is expensive. -2
  • The TTM is -4.937. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-52.705MRQ-55.575+2.870
MRQ-55.575TTM-4.937-50.638
TTM-4.937YOY5.330-10.267
TTM-4.9375Y16.080-21.017
5Y16.08010Y63.456-47.376
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Tibet Rhodiola Pharmaceutical Holding Co:

  • The EOD is 10.350. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 10.913. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 14.254. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD10.350MRQ10.913-0.564
MRQ10.913TTM14.254-3.341
TTM14.254YOY13.376+0.878
TTM14.2545Y-264.827+279.082
5Y-264.82710Y-114.306-150.521
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Tibet Rhodiola Pharmaceutical Holding Co is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Tibet Rhodiola Pharmaceutical Holding Co:

  • The EOD is 3.401. Based on the equity, the company is fair priced.
  • The MRQ is 3.586. Based on the equity, the company is fair priced.
  • The TTM is 3.834. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD3.401MRQ3.586-0.185
MRQ3.586TTM3.834-0.247
TTM3.834YOY3.254+0.580
TTM3.8345Y4.300-0.467
5Y4.30010Y9.670-5.370
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Tibet Rhodiola Pharmaceutical Holding Co compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.2930.346-185%0.389-175%0.225-230%0.300-198%
Book Value Per Share--13.60713.786-1%11.953+14%11.334+20%7.796+75%
Current Ratio--2.8732.715+6%2.340+23%3.163-9%1.876+53%
Debt To Asset Ratio--0.2650.273-3%0.282-6%0.202+31%0.321-18%
Debt To Equity Ratio--0.3630.379-4%0.396-8%0.267+36%0.715-49%
Dividend Per Share--0.0110.684-98%0.099-89%0.286-96%0.194-94%
Eps---0.2200.797-128%0.373-159%0.423-152%0.289-176%
Free Cash Flow Per Share--1.1181.050+6%0.742+51%0.477+134%0.175+539%
Free Cash Flow To Equity Per Share--1.1180.853+31%0.595+88%0.359+211%0.309+262%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%0.975+3%
Intrinsic Value_10Y_max--60.165--------
Intrinsic Value_10Y_min--50.776--------
Intrinsic Value_1Y_max--2.852--------
Intrinsic Value_1Y_min--2.800--------
Intrinsic Value_3Y_max--10.991--------
Intrinsic Value_3Y_min--10.444--------
Intrinsic Value_5Y_max--22.048--------
Intrinsic Value_5Y_min--20.256--------
Market Cap11474570640.000-5%12099374400.00013111581285.000-8%9584043390.000+26%11938837024.380+1%10864334477.190+11%
Net Profit Margin---0.0710.264-127%0.141-150%0.215-133%0.188-138%
Operating Margin---0.087-100%0.270-100%0.243-100%0.140-100%
Operating Ratio--0.6570.646+2%0.762-14%0.787-16%0.639+3%
Pb Ratio3.401-5%3.5863.834-6%3.254+10%4.300-17%9.670-63%
Pe Ratio-52.705+5%-55.575-4.937-91%5.330-1143%16.080-446%63.456-188%
Price Per Share46.280-5%48.80052.883-8%38.655+26%48.153+1%43.819+11%
Price To Free Cash Flow Ratio10.350-5%10.91314.254-23%13.376-18%-264.827+2527%-114.306+1147%
Price To Total Gains Ratio-164.258+5%-173.202-13.113-92%20.055-964%92.394-287%1162.777-115%
Quick Ratio--0.9851.139-14%1.211-19%1.276-23%0.963+2%
Return On Assets---0.0120.042-128%0.022-153%0.029-141%0.026-146%
Return On Equity---0.0160.059-128%0.032-151%0.037-145%0.040-140%
Total Gains Per Share---0.2821.029-127%0.488-158%0.511-155%0.494-157%
Usd Book Value--466234382.521472373684.649-1%409563982.360+14%388372387.420+20%267133640.996+75%
Usd Book Value Change Per Share---0.0400.048-185%0.054-175%0.031-230%0.041-198%
Usd Book Value Per Share--1.8801.905-1%1.652+14%1.566+20%1.077+75%
Usd Dividend Per Share--0.0020.094-98%0.014-89%0.040-96%0.027-94%
Usd Eps---0.0300.110-128%0.052-159%0.059-152%0.040-176%
Usd Free Cash Flow--38304339.33335991881.354+6%25408547.966+51%16346088.930+134%4945137.179+675%
Usd Free Cash Flow Per Share--0.1540.145+6%0.102+51%0.066+134%0.024+539%
Usd Free Cash Flow To Equity Per Share--0.1540.118+31%0.082+88%0.050+211%0.043+262%
Usd Market Cap1585785662.448-5%1672133542.0801812020533.587-8%1324514796.498+26%1649947276.769+1%1501451024.748+11%
Usd Price Per Share6.396-5%6.7447.308-8%5.342+26%6.655+1%6.056+11%
Usd Profit---7521938.83327671578.075-127%12776868.055-159%14580633.293-152%9936953.772-176%
Usd Revenue--105905207.273108291044.499-2%88261743.238+20%72255458.635+47%56137908.526+89%
Usd Total Gains Per Share---0.0390.142-127%0.067-158%0.071-155%0.068-157%
 EOD+4 -4MRQTTM+12 -23YOY+18 -175Y+15 -2010Y+19 -17

3.2. Fundamental Score

Let's check the fundamental score of Tibet Rhodiola Pharmaceutical Holding Co based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-52.705
Price to Book Ratio (EOD)Between0-13.401
Net Profit Margin (MRQ)Greater than0-0.071
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.985
Current Ratio (MRQ)Greater than12.873
Debt to Asset Ratio (MRQ)Less than10.265
Debt to Equity Ratio (MRQ)Less than10.363
Return on Equity (MRQ)Greater than0.15-0.016
Return on Assets (MRQ)Greater than0.05-0.012
Total3/10 (30.0%)

3.3. Technical Score

Let's check the technical score of Tibet Rhodiola Pharmaceutical Holding Co based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5056.328
Ma 20Greater thanMa 5045.080
Ma 50Greater thanMa 10044.624
Ma 100Greater thanMa 20046.411
OpenGreater thanClose45.900
Total2/5 (40.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Tax Provision  22,4479,13331,5801,24132,822-6,07426,748-29,947-3,200



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets4,587,357
Total Liabilities1,213,736
Total Stockholder Equity3,344,589
 As reported
Total Liabilities 1,213,736
Total Stockholder Equity+ 3,344,589
Total Assets = 4,587,357

Assets

Total Assets4,587,357
Total Current Assets3,402,862
Long-term Assets1,184,495
Total Current Assets
Cash And Cash Equivalents 1,859,790
Short-term Investments 515,337
Net Receivables 650,930
Inventory 111,435
Other Current Assets 34,261
Total Current Assets  (as reported)3,402,862
Total Current Assets  (calculated)3,171,753
+/- 231,109
Long-term Assets
Property Plant Equipment 600,329
Goodwill 8,877
Intangible Assets 203,774
Long-term Assets Other 4,716
Long-term Assets  (as reported)1,184,495
Long-term Assets  (calculated)817,695
+/- 366,800

Liabilities & Shareholders' Equity

Total Current Liabilities1,184,470
Long-term Liabilities29,266
Total Stockholder Equity3,344,589
Total Current Liabilities
Short Long Term Debt 499,985
Accounts payable 38,888
Other Current Liabilities 1,473
Total Current Liabilities  (as reported)1,184,470
Total Current Liabilities  (calculated)540,347
+/- 644,124
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt1,125
Long-term Liabilities  (as reported)29,266
Long-term Liabilities  (calculated)1,125
+/- 28,141
Total Stockholder Equity
Retained Earnings 1,646,830
Total Stockholder Equity (as reported)3,344,589
Total Stockholder Equity (calculated)1,646,830
+/- 1,697,759
Other
Capital Stock247,938
Common Stock Shares Outstanding 247,938
Net Invested Capital 3,844,574
Net Working Capital 2,218,392
Property Plant and Equipment Gross 600,329



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-09-302002-06-302002-03-312001-12-312001-06-302000-12-312000-06-30
> Total Assets 
433,063
528,361
553,929
608,325
605,447
742,198
762,250
733,079
755,428
740,549
746,756
754,356
754,744
746,091
748,037
777,253
823,560
846,761
872,834
820,620
822,004
796,672
849,071
866,902
874,097
842,288
859,614
831,963
771,831
806,794
814,984
829,661
784,590
784,177
782,716
743,703
738,576
691,868
704,446
735,469
741,534
715,858
730,280
787,864
802,647
813,490
861,196
845,151
870,174
884,047
922,044
1,137,461
1,125,890
1,106,216
1,076,339
1,046,444
1,099,915
981,229
669,044
706,330
725,945
2,077,629
2,156,685
2,290,679
2,272,267
3,561,435
2,866,144
2,330,045
2,315,616
2,362,541
2,599,240
2,532,052
2,647,693
2,584,986
2,671,187
2,767,231
2,886,410
2,819,990
2,923,477
2,944,288
3,228,301
3,455,839
3,753,629
3,802,656
4,036,145
4,046,895
4,328,100
4,099,412
4,657,241
4,849,559
4,721,415
4,587,357
4,587,3574,721,4154,849,5594,657,2414,099,4124,328,1004,046,8954,036,1453,802,6563,753,6293,455,8393,228,3012,944,2882,923,4772,819,9902,886,4102,767,2312,671,1872,584,9862,647,6932,532,0522,599,2402,362,5412,315,6162,330,0452,866,1443,561,4352,272,2672,290,6792,156,6852,077,629725,945706,330669,044981,2291,099,9151,046,4441,076,3391,106,2161,125,8901,137,461922,044884,047870,174845,151861,196813,490802,647787,864730,280715,858741,534735,469704,446691,868738,576743,703782,716784,177784,590829,661814,984806,794771,831831,963859,614842,288874,097866,902849,071796,672822,004820,620872,834846,761823,560777,253748,037746,091754,744754,356746,756740,549755,428733,079762,250742,198605,447608,325553,929528,361433,063
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
872,597
1,075,865
1,087,632
1,234,788
1,161,094
1,221,562
1,341,035
1,458,763
1,323,795
1,308,022
1,351,115
1,470,997
1,478,360
1,696,881
2,181,907
2,453,960
2,453,960
2,710,344
2,712,114
3,294,997
3,478,404
3,343,904
3,402,862
3,402,8623,343,9043,478,4043,294,9972,712,1142,710,3442,453,9602,453,9602,181,9071,696,8811,478,3601,470,9971,351,1151,308,0221,323,7951,458,7631,341,0351,221,5621,161,0941,234,7881,087,6321,075,865872,597000000000000000000000000000000000000000000000000000000000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
370,486
546,248
529,334
657,674
719,465
722,699
740,344
973,949
615,834
536,863
768,521
705,087
767,107
726,246
764,415
936,642
922,901
1,305,987
1,139,830
1,469,808
1,412,977
1,685,687
1,859,790
1,859,7901,685,6871,412,9771,469,8081,139,8301,305,987922,901936,642764,415726,246767,107705,087768,521536,863615,834973,949740,344722,699719,465657,674529,334546,248370,486000000000000000000000000000000000000000000000000000000000000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
75
90,000
48
180,000
180,009
14,962
181,536
19,474
217,746
537,866
574,121
731,218
609,870
792,491
950,390
1,060,077
829,849
515,337
515,337829,8491,060,077950,390792,491609,870731,218574,121537,866217,74619,474181,53614,962180,009180,0004890,0007500000000000000000000000000000000000000000000000000000000000000000000000000
       Net Receivables 
91,339
88,348
106,153
118,250
155,416
181,930
165,619
180,784
186,698
190,139
188,652
195,171
195,029
193,335
205,237
179,598
218,950
206,653
216,805
232,820
256,316
243,357
273,598
311,524
304,976
136,261
152,361
180,156
176,063
207,497
223,419
189,043
235,314
253,565
180,522
153,489
170,755
164,092
176,768
133,459
187,239
134,934
136,218
132,634
161,208
175,056
175,427
148,609
181,409
169,602
193,734
152,748
247,656
254,172
231,150
170,702
256,504
169,053
33,149
37,031
29,873
135,221
179,235
105,417
109,529
207,952
299,238
404,977
403,730
421,058
466,856
493,090
422,734
302,750
329,828
419,291
379,495
422,162
474,482
488,761
505,201
560,226
553,469
645,153
668,751
668,751
654,446
638,312
436,755
872,279
396,916
650,930
650,930396,916872,279436,755638,312654,446668,751668,751645,153553,469560,226505,201488,761474,482422,162379,495419,291329,828302,750422,734493,090466,856421,058403,730404,977299,238207,952109,529105,417179,235135,22129,87337,03133,149169,053256,504170,702231,150254,172247,656152,748193,734169,602181,409148,609175,427175,056161,208132,634136,218134,934187,239133,459176,768164,092170,755153,489180,522253,565235,314189,043223,419207,497176,063180,156152,361136,261304,976311,524273,598243,357256,316232,820216,805206,653218,950179,598205,237193,335195,029195,171188,652190,139186,698180,784165,619181,930155,416118,250106,15388,34891,339
       Inventory 
15,925
13,925
12,368
16,895
16,691
16,771
18,442
15,810
16,821
17,862
18,222
17,555
18,590
18,135
23,533
46,964
66,654
67,870
81,663
52,475
69,333
68,529
71,330
70,641
92,728
94,840
94,289
92,787
93,486
86,021
90,079
205,475
200,845
188,077
187,982
207,012
225,031
204,183
196,675
235,212
226,572
224,661
217,494
220,415
223,466
213,551
223,166
218,837
226,788
246,277
229,484
266,989
289,410
314,974
299,657
305,483
305,026
256,386
134,980
126,134
131,512
180,158
179,651
94,244
100,180
103,047
89,639
86,654
84,339
79,103
61,542
62,272
61,261
66,162
55,934
74,604
88,766
89,293
72,045
70,855
67,035
80,510
119,021
137,318
102,279
102,279
100,799
99,948
94,807
100,415
115,520
111,435
111,435115,520100,41594,80799,948100,799102,279102,279137,318119,02180,51067,03570,85572,04589,29388,76674,60455,93466,16261,26162,27261,54279,10384,33986,65489,639103,047100,18094,244179,651180,158131,512126,134134,980256,386305,026305,483299,657314,974289,410266,989229,484246,277226,788218,837223,166213,551223,466220,415217,494224,661226,572235,212196,675204,183225,031207,012187,982188,077200,845205,47590,07986,02193,48692,78794,28994,84092,72870,64171,33068,52969,33352,47581,66367,87066,65446,96423,53318,13518,59017,55518,22217,86216,82115,81018,44216,77116,69116,89512,36813,92515,925
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,412,905
1,423,892
1,449,625
1,426,197
1,427,647
1,496,195
1,615,455
1,593,173
1,757,304
1,977,479
2,056,748
1,620,749
1,652,486
1,592,935
1,617,756
1,387,298
1,362,244
1,371,154
1,377,510
1,184,495
1,184,4951,377,5101,371,1541,362,2441,387,2981,617,7561,592,9351,652,4861,620,7492,056,7481,977,4791,757,3041,593,1731,615,4551,496,1951,427,6471,426,1971,449,6251,423,8921,412,905000000000000000000000000000000000000000000000000000000000000000000000000
       Property Plant Equipment 
138,359
252,508
254,679
239,288
248,998
253,652
257,371
267,613
271,910
273,674
276,423
281,254
287,571
291,328
292,545
294,114
294,311
300,287
292,838
256,182
218,977
251,954
215,499
249,444
166,824
200,315
163,383
194,093
157,199
189,338
153,560
95,388
86,490
92,469
84,700
101,539
92,033
99,404
91,191
96,540
88,420
85,162
76,783
92,171
83,813
88,960
80,634
102,015
96,079
120,964
99,331
111,741
91,337
97,976
105,467
108,806
106,652
108,060
105,390
106,558
105,453
104,114
103,978
148,488
146,256
147,078
147,769
149,779
147,865
147,012
149,617
151,141
151,473
164,433
185,782
190,216
189,177
191,669
198,684
204,457
346,443
617,796
811,950
764,543
770,963
770,963
773,895
551,383
603,719
603,612
598,835
600,329
600,329598,835603,612603,719551,383773,895770,963770,963764,543811,950617,796346,443204,457198,684191,669189,177190,216185,782164,433151,473151,141149,617147,012147,865149,779147,769147,078146,256148,488103,978104,114105,453106,558105,390108,060106,652108,806105,46797,97691,337111,74199,331120,96496,079102,01580,63488,96083,81392,17176,78385,16288,42096,54091,19199,40492,033101,53984,70092,46986,49095,388153,560189,338157,199194,093163,383200,315166,824249,444215,499251,954218,977256,182292,838300,287294,311294,114292,545291,328287,571281,254276,423273,674271,910267,613257,371253,652248,998239,288254,679252,508138,359
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
9,173
9,173
9,173
9,173
9,173
9,173
8,877
8,877
8,877
8,877
8,877
8,877
8,877
8,877
8,877
8,877
8,877
8,877
8,877
8,877
8,877
8,877
8,877
8,877
8,877
8,877
8,877
8,877
8,877
8,877
8,877
8,877
8,877
8,877
8,877
8,877
8,877
8,877
8,877
8,877
8,8778,8778,8778,8778,8778,8778,8778,8778,8778,8778,8778,8778,8778,8778,8778,8778,8778,8778,8778,8778,8778,8778,8778,8778,8778,8778,8778,8778,8778,8778,8778,8778,8778,8779,1739,1739,1739,1739,1739,1730000000000000000000000000000000000000000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
106,392
104,726
83,495
81,458
79,632
78,697
80,806
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000080,80678,69779,63281,45883,495104,726106,392000000000000000000000000000000000000000000000000000000000000000000000
       Intangible Assets 
18,658
5,516
5,273
8,463
8,343
79,523
77,907
81,124
79,685
78,047
76,671
74,360
72,714
70,998
69,307
67,620
66,029
57,784
62,848
59,690
92,792
56,207
88,917
56,296
100,007
52,456
100,396
45,323
107,827
41,869
105,487
38,416
76,808
34,938
73,952
31,512
72,186
28,058
68,203
24,628
64,741
21,189
61,270
17,750
57,664
13,611
53,271
11,626
45,952
6,783
60,399
0
32,934
32,696
32,560
32,419
32,277
32,136
31,708
31,576
31,445
1,280,742
1,273,532
1,330,572
1,307,005
1,267,984
1,227,332
1,193,394
1,135,309
1,166,864
1,194,726
1,115,984
1,095,916
1,058,551
1,117,479
1,088,567
1,088,412
1,072,574
1,019,221
964,452
956,045
938,842
939,894
456,481
451,458
418,222
432,501
417,750
405,505
416,661
406,731
203,774
203,774406,731416,661405,505417,750432,501418,222451,458456,481939,894938,842956,045964,4521,019,2211,072,5741,088,4121,088,5671,117,4791,058,5511,095,9161,115,9841,194,7261,166,8641,135,3091,193,3941,227,3321,267,9841,307,0051,330,5721,273,5321,280,74231,44531,57631,70832,13632,27732,41932,56032,69632,934060,3996,78345,95211,62653,27113,61157,66417,75061,27021,18964,74124,62868,20328,05872,18631,51273,95234,93876,80838,416105,48741,869107,82745,323100,39652,456100,00756,29688,91756,20792,79259,69062,84857,78466,02967,62069,30770,99872,71474,36076,67178,04779,68581,12477,90779,5238,3438,4635,2735,51618,658
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
34,918
35,217
3,469
1,874
2,873
39,182
182,835
219,714
253,414
220,071
101,433
42,385
70,577
57,806
62,418
66,066
9,944
8,940
8,098
4,716
4,7168,0988,9409,94466,06662,41857,80670,57742,385101,433220,071253,414219,714182,83539,1822,8731,8743,46935,21734,918000000000000000000000000000000000000000000000000000000000000000000000000
> Total Liabilities 
30,020
126,012
150,518
201,823
198,620
330,233
350,157
314,231
336,334
318,721
323,264
329,822
329,751
318,695
318,455
341,743
388,810
410,341
435,700
427,370
429,789
401,227
451,328
470,559
485,153
491,790
526,259
557,681
499,876
531,947
540,070
550,509
504,251
498,056
485,173
443,705
436,586
387,202
392,280
411,281
417,078
380,822
389,752
432,929
445,090
447,455
483,116
459,716
482,474
499,758
536,580
738,256
719,310
697,084
653,663
632,260
676,473
550,095
210,265
220,430
219,590
1,557,994
1,579,125
1,632,490
1,558,245
1,616,808
898,995
284,642
251,730
237,831
316,172
274,895
346,258
317,900
279,008
320,441
286,488
316,368
374,065
355,906
470,585
705,863
877,188
1,157,635
1,219,400
1,164,990
1,203,281
1,068,642
1,292,285
1,362,221
1,275,153
1,213,736
1,213,7361,275,1531,362,2211,292,2851,068,6421,203,2811,164,9901,219,4001,157,635877,188705,863470,585355,906374,065316,368286,488320,441279,008317,900346,258274,895316,172237,831251,730284,642898,9951,616,8081,558,2451,632,4901,579,1251,557,994219,590220,430210,265550,095676,473632,260653,663697,084719,310738,256536,580499,758482,474459,716483,116447,455445,090432,929389,752380,822417,078411,281392,280387,202436,586443,705485,173498,056504,251550,509540,070531,947499,876557,681526,259491,790485,153470,559451,328401,227429,789427,370435,700410,341388,810341,743318,455318,695329,751329,822323,264318,721336,334314,231350,157330,233198,620201,823150,518126,01230,020
   > Total Current Liabilities 
30,020
96,012
120,519
197,023
192,620
324,233
344,156
308,232
330,333
312,721
317,264
323,292
323,220
312,165
311,925
335,212
381,829
403,361
428,721
420,339
422,759
394,197
443,798
463,128
478,023
484,531
518,999
550,421
492,117
524,187
527,810
537,834
491,618
485,423
472,551
429,617
422,498
372,301
377,474
395,468
401,359
365,196
373,220
416,561
426,858
426,466
462,240
441,490
464,142
475,259
510,975
713,708
694,156
671,094
627,367
605,339
649,587
523,313
183,533
192,222
191,445
1,530,029
1,551,219
1,604,722
1,530,540
948,534
259,089
264,264
231,432
218,190
298,084
261,267
332,737
304,485
265,697
309,846
276,096
306,078
363,878
333,077
452,795
688,217
860,559
1,109,665
1,120,327
1,120,327
1,159,259
1,026,205
1,250,146
1,319,577
1,231,588
1,184,470
1,184,4701,231,5881,319,5771,250,1461,026,2051,159,2591,120,3271,120,3271,109,665860,559688,217452,795333,077363,878306,078276,096309,846265,697304,485332,737261,267298,084218,190231,432264,264259,089948,5341,530,5401,604,7221,551,2191,530,029191,445192,222183,533523,313649,587605,339627,367671,094694,156713,708510,975475,259464,142441,490462,240426,466426,858416,561373,220365,196401,359395,468377,474372,301422,498429,617472,551485,423491,618537,834527,810524,187492,117550,421518,999484,531478,023463,128443,798394,197422,759420,339428,721403,361381,829335,212311,925312,165323,220323,292317,264312,721330,333308,232344,156324,233192,620197,023120,51996,01230,020
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
50,000
50,000
0
40,000
253,034
410,000
534,661
570,000
550,414
650,383
486,103
540,367
629,135
755,522
499,985
499,985755,522629,135540,367486,103650,383550,414570,000534,661410,000253,03440,000050,00050,00000000000000000000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
15,094
4,624
2,857
2,998
1,742
2,001
2,843
4,482
3,302
3,864
6,489
10,584
6,792
6,820
11,880
40,716
74,845
83,689
114,088
107,299
120,468
113,798
137,729
144,710
172,684
173,135
163,817
169,422
168,247
183,739
193,144
201,878
210,079
196,804
224,073
210,533
218,594
165,893
165,139
191,199
201,685
157,464
147,212
176,736
184,537
187,313
216,883
209,768
220,467
219,997
218,233
219,055
247,440
266,734
260,137
226,535
239,210
190,331
7,481
5,929
7,920
36,380
24,494
10,977
595,121
10,284
34,165
9,808
7,674
20,074
17,148
8,080
7,608
7,275
8,660
11,152
8,209
6,969
9,458
7,190
10,170
17,575
42,376
13,218
25,707
25,707
49,415
14,371
47,052
8,327
44,481
38,888
38,88844,4818,32747,05214,37149,41525,70725,70713,21842,37617,57510,1707,1909,4586,9698,20911,1528,6607,2757,6088,08017,14820,0747,6749,80834,16510,284595,12110,97724,49436,3807,9205,9297,481190,331239,210226,535260,137266,734247,440219,055218,233219,997220,467209,768216,883187,313184,537176,736147,212157,464201,685191,199165,139165,893218,594210,533224,073196,804210,079201,878193,144183,739168,247169,422163,817173,135172,684144,710137,729113,798120,468107,299114,08883,68974,84540,71611,8806,8206,79210,5846,4893,8643,3024,4822,8432,0011,7422,9982,8574,62415,094
       Other Current Liabilities 
14,926
61,388
27,662
30,025
26,878
47,232
67,313
29,750
23,031
25,857
26,775
30,908
34,628
43,545
38,245
32,696
44,184
56,872
51,833
56,040
60,991
75,099
101,349
113,618
108,669
140,896
203,913
251,230
193,601
210,179
217,897
196,187
141,770
148,850
153,709
124,315
109,135
111,639
117,566
101,500
96,905
104,963
123,239
110,056
112,552
109,384
115,588
116,953
118,906
130,493
167,973
379,884
321,947
279,591
242,461
244,035
275,607
228,213
131,284
141,523
138,756
745,000
1,481,956
1,548,976
890,650
186,454
224,924
254,457
223,758
51,826
271,507
65,260
315,246
53,273
245,685
58,774
254,501
56,627
293,624
54,737
388,420
69,118
392,069
160,987
110,733
110,733
438,993
112,027
418
120,725
1,247
1,473
1,4731,247120,725418112,027438,993110,733110,733160,987392,06969,118388,42054,737293,62456,627254,50158,774245,68553,273315,24665,260271,50751,826223,758254,457224,924186,454890,6501,548,9761,481,956745,000138,756141,523131,284228,213275,607244,035242,461279,591321,947379,884167,973130,493118,906116,953115,588109,384112,552110,056123,239104,96396,905101,500117,566111,639109,135124,315153,709148,850141,770196,187217,897210,179193,601251,230203,913140,896108,669113,618101,34975,09960,99156,04051,83356,87244,18432,69638,24543,54534,62830,90826,77525,85723,03129,75067,31347,23226,87830,02527,66261,38814,926
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
13,521
13,415
13,311
10,595
10,392
10,290
10,187
22,829
17,790
17,646
16,629
47,970
45,885
44,663
44,022
42,436
42,139
42,644
43,565
29,266
29,26643,56542,64442,13942,43644,02244,66345,88547,97016,62917,64617,79022,82910,18710,29010,39210,59513,31113,41513,521000000000000000000000000000000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
4,800
6,000
6,000
6,001
5,999
6,001
6,000
6,000
6,530
6,531
6,530
6,530
6,531
6,981
6,980
6,979
7,031
7,030
7,030
7,530
7,431
7,130
7,259
7,260
7,260
7,759
7,760
12,260
12,675
12,633
12,633
12,622
14,088
14,088
14,901
14,806
15,813
15,719
15,626
16,532
16,368
18,232
20,989
20,876
18,226
18,332
24,499
25,605
24,548
25,154
25,990
26,297
26,303
26,207
26,411
26,315
27,780
27,685
27,589
27,493
27,057
26,958
26,859
25,560
19,460
19,361
19,641
18,088
13,627
13,521
13,415
13,311
10,595
10,392
10,290
10,187
12,414
14,479
12,971
12,749
46,108
43,376
43,376
43,198
41,292
0
41,618
0
0
0041,618041,29243,19843,37643,37646,10812,74912,97114,47912,41410,18710,29010,39210,59513,31113,41513,52113,62718,08819,64119,36119,46025,56026,85926,95827,05727,49327,58927,68527,78026,31526,41126,20726,30326,29725,99025,15424,54825,60524,49918,33218,22620,87620,98918,23216,36816,53215,62615,71915,81314,80614,90114,08814,08812,62212,63312,63312,67512,2607,7607,7597,2607,2607,2597,1307,4317,5307,0307,0307,0316,9796,9806,9816,5316,5306,5306,5316,5306,0006,0006,0015,9996,0016,0006,0004,800000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
14,825
15,035
15,404
15,637
17,702
18,326
19,751
19,736
20,845
21,411
21,530
21,631
34,736
48,062
47,694
3,676
3,676
3,354
2,791
0
2,367
0
0
002,36702,7913,3543,6763,67647,69448,06234,73621,63121,53021,41120,84519,73619,75118,32617,70215,63715,40415,03514,825000000000000000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
400,856
401,044
402,548
404,173
404,506
409,653
409,777
414,371
414,623
417,374
419,038
420,145
420,410
423,184
424,872
426,227
426,531
428,125
428,919
384,903
383,461
386,019
388,102
387,980
380,607
342,658
326,134
269,206
266,211
269,504
270,293
275,692
276,608
281,868
293,547
294,779
296,352
299,030
306,708
319,452
320,053
325,653
331,519
339,966
342,956
351,298
364,077
371,641
374,439
371,404
375,064
388,603
396,747
400,406
414,684
404,354
413,277
421,723
462,050
489,453
509,830
523,116
579,804
660,635
715,609
1,945,466
1,967,251
2,043,203
2,061,276
2,121,690
2,279,208
2,252,476
2,296,103
2,260,474
2,383,955
2,437,060
2,589,419
2,492,296
2,537,236
2,576,085
2,744,035
2,735,516
2,860,986
2,630,359
2,800,502
2,864,302
3,105,975
3,011,740
3,343,610
3,464,378
3,419,052
3,344,589
3,344,5893,419,0523,464,3783,343,6103,011,7403,105,9752,864,3022,800,5022,630,3592,860,9862,735,5162,744,0352,576,0852,537,2362,492,2962,589,4192,437,0602,383,9552,260,4742,296,1032,252,4762,279,2082,121,6902,061,2762,043,2031,967,2511,945,466715,609660,635579,804523,116509,830489,453462,050421,723413,277404,354414,684400,406396,747388,603375,064371,404374,439371,641364,077351,298342,956339,966331,519325,653320,053319,452306,708299,030296,352294,779293,547281,868276,608275,692270,293269,504266,211269,206326,134342,658380,607387,980388,102386,019383,461384,903428,919428,125426,531426,227424,872423,184420,410420,145419,038417,374414,623414,371409,777409,653404,506404,173402,548401,044400,856
   Common Stock
122,600
122,600
122,600
122,600
122,600
122,600
122,600
122,600
122,600
122,600
122,600
122,600
122,600
122,600
122,600
122,600
122,600
122,600
122,600
122,600
122,600
122,600
122,600
122,600
122,600
122,600
138,710
138,710
138,710
138,710
138,710
138,710
138,710
138,710
138,710
138,710
138,710
138,710
145,589
145,589
145,589
145,589
145,589
145,589
145,589
145,589
145,589
145,589
145,589
145,589
145,589
145,589
145,589
145,589
145,589
145,589
145,589
145,589
145,589
145,589
145,589
145,589
145,589
145,589
145,589
179,619
179,619
179,619
179,619
179,619
179,619
179,619
179,619
179,619
179,619
177,098
177,098
247,938
247,938
247,938
247,938
247,938
247,938
247,938
247,938
247,938
247,938
247,938
0
247,938
0
0
00247,9380247,938247,938247,938247,938247,938247,938247,938247,938247,938247,938247,938177,098177,098179,619179,619179,619179,619179,619179,619179,619179,619179,619179,619145,589145,589145,589145,589145,589145,589145,589145,589145,589145,589145,589145,589145,589145,589145,589145,589145,589145,589145,589145,589145,589145,589145,589145,589145,589145,589145,589138,710138,710138,710138,710138,710138,710138,710138,710138,710138,710138,710138,710122,600122,600122,600122,600122,600122,600122,600122,600122,600122,600122,600122,600122,600122,600122,600122,600122,600122,600122,600122,600122,600122,600122,600122,600122,600122,600
   Retained Earnings 
34,916
29,692
31,077
31,515
31,515
36,995
37,119
39,985
40,238
42,988
44,652
44,822
45,087
47,861
49,549
48,987
49,291
50,885
51,679
6,766
5,324
7,882
9,965
9,750
2,378
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
34,489
38,148
48,464
38,590
46,904
55,725
95,578
122,865
142,918
156,911
213,214
293,493
347,627
351,665
368,629
463,505
532,169
524,036
625,499
609,958
597,269
617,440
699,146
855,820
984,352
888,003
992,546
1,086,192
1,243,370
1,257,980
1,378,228
1,168,681
1,347,128
1,347,128
1,527,511
1,454,686
1,632,067
1,865,661
1,701,258
1,646,830
1,646,8301,701,2581,865,6611,632,0671,454,6861,527,5111,347,1281,347,1281,168,6811,378,2281,257,9801,243,3701,086,192992,546888,003984,352855,820699,146617,440597,269609,958625,499524,036532,169463,505368,629351,665347,627293,493213,214156,911142,918122,86595,57855,72546,90438,59048,46438,14834,4890000000000000000000000000002,3789,7509,9657,8825,3246,76651,67950,88549,29148,98749,54947,86145,08744,82244,65242,98840,23839,98537,11936,99531,51531,51531,07729,69234,916
   Capital Surplus 00000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock00000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
9,066
65,120
53,929
26,839
56,044
97,820
77,657
101,485
100,710
1,296,752
-22,408
-11,637
-34,766
-29,543
-51,420
4,076
4,076
65,367
42,978
0
84,641
0
0
0084,641042,97865,3674,0764,076-51,420-29,543-34,766-11,637-22,4081,296,752100,710101,48577,65797,82056,04426,83953,92965,1209,066000000000000000000000000000000000000000000000000000000000000000000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue3,134,328
Cost of Revenue-155,085
Gross Profit2,979,2442,979,244
 
Operating Income (+$)
Gross Profit2,979,244
Operating Expense-1,905,270
Operating Income1,229,0581,073,973
 
Operating Expense (+$)
Research Development17,350
Selling General Administrative1,806,335
Selling And Marketing Expenses0
Operating Expense1,905,2701,823,685
 
Net Interest Income (+$)
Interest Income45,779
Interest Expense-11,594
Other Finance Cost-359
Net Interest Income33,826
 
Pretax Income (+$)
Operating Income1,229,058
Net Interest Income33,826
Other Non-Operating Income Expenses0
Income Before Tax (EBT)898,1951,229,058
EBIT - interestExpense = -11,594
800,914
812,508
Interest Expense11,594
Earnings Before Interest and Taxes (EBIT)0909,789
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax898,195
Tax Provision-87,950
Net Income From Continuing Ops810,245810,245
Net Income800,914
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0-33,826
 

Technical Analysis of Tibet Rhodiola Pharmaceutical Holding Co
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Tibet Rhodiola Pharmaceutical Holding Co. The general trend of Tibet Rhodiola Pharmaceutical Holding Co is BEARISH with 42.9% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Tibet Rhodiola Pharmaceutical Holding Co's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-42.9%) Bearish trend (42.9%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Tibet Rhodiola Pharmaceutical Holding Co.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 47.44 < 47.88 < 49.61.

The bearish price targets are: 43.50 > 36.98 > 35.60.

Tweet this
Tibet Rhodiola Pharmaceutical Holding Co Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Tibet Rhodiola Pharmaceutical Holding Co. The current mas is .

The long score for the Moving Averages is 4/14.
The longshort score for the Moving Averages is -6/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Tibet Rhodiola Pharmaceutical Holding Co Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Tibet Rhodiola Pharmaceutical Holding Co. The current macd is 0.09074162.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Tibet Rhodiola Pharmaceutical Holding Co price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Tibet Rhodiola Pharmaceutical Holding Co. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Tibet Rhodiola Pharmaceutical Holding Co price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Tibet Rhodiola Pharmaceutical Holding Co Daily Moving Average Convergence/Divergence (MACD) ChartTibet Rhodiola Pharmaceutical Holding Co Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Tibet Rhodiola Pharmaceutical Holding Co. The current adx is 16.48.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Tibet Rhodiola Pharmaceutical Holding Co shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
Tibet Rhodiola Pharmaceutical Holding Co Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Tibet Rhodiola Pharmaceutical Holding Co. The current sar is 43.73.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Tibet Rhodiola Pharmaceutical Holding Co Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Tibet Rhodiola Pharmaceutical Holding Co. The current rsi is 56.33. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending up: The RSI is trending up. +1
Tibet Rhodiola Pharmaceutical Holding Co Daily Relative Strength Index (RSI) ChartTibet Rhodiola Pharmaceutical Holding Co Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Tibet Rhodiola Pharmaceutical Holding Co. The current phase is Overbought in bear market.

The long score for the Stochastic Oscillator is 6/6.
The longshort score for the Stochastic Oscillator is 6/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Tibet Rhodiola Pharmaceutical Holding Co price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Tibet Rhodiola Pharmaceutical Holding Co Daily Stochastic Oscillator ChartTibet Rhodiola Pharmaceutical Holding Co Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Tibet Rhodiola Pharmaceutical Holding Co. The current cci is 106.65.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
Tibet Rhodiola Pharmaceutical Holding Co Daily Commodity Channel Index (CCI) ChartTibet Rhodiola Pharmaceutical Holding Co Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Tibet Rhodiola Pharmaceutical Holding Co. The current cmo is 21.23.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Tibet Rhodiola Pharmaceutical Holding Co Daily Chande Momentum Oscillator (CMO) ChartTibet Rhodiola Pharmaceutical Holding Co Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Tibet Rhodiola Pharmaceutical Holding Co. The current willr is -15.24390244.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Tibet Rhodiola Pharmaceutical Holding Co Daily Williams %R ChartTibet Rhodiola Pharmaceutical Holding Co Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Tibet Rhodiola Pharmaceutical Holding Co.

Tibet Rhodiola Pharmaceutical Holding Co Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Tibet Rhodiola Pharmaceutical Holding Co. The current atr is 1.36302035.

Tibet Rhodiola Pharmaceutical Holding Co Daily Average True Range (ATR) ChartTibet Rhodiola Pharmaceutical Holding Co Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Tibet Rhodiola Pharmaceutical Holding Co. The current obv is 89,504,619.

Tibet Rhodiola Pharmaceutical Holding Co Daily On-Balance Volume (OBV) ChartTibet Rhodiola Pharmaceutical Holding Co Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Tibet Rhodiola Pharmaceutical Holding Co. The current mfi is 65.50.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Tibet Rhodiola Pharmaceutical Holding Co Daily Money Flow Index (MFI) ChartTibet Rhodiola Pharmaceutical Holding Co Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Tibet Rhodiola Pharmaceutical Holding Co.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-22STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-27SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-11-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-11-29CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-30STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-04STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-05WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-06CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-07DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-08STOCH SHORT EXITThe %K line crosses above the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-12MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-13DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-15STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-19CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-20DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2023-12-26CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-28SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-04WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-05CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-10RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-15RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-16WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-19RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-01-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-30CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-31SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-02BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-06RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-07MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-21DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-04MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-07CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-08STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-12CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-13BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-21SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-25DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-26DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-27STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-28CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-01STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-02CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-03CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-08STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-15DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-16SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-18MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside

6.3. Candlestick Patterns

Tibet Rhodiola Pharmaceutical Holding Co Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Tibet Rhodiola Pharmaceutical Holding Co based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5056.328
Ma 20Greater thanMa 5045.080
Ma 50Greater thanMa 10044.624
Ma 100Greater thanMa 20046.411
OpenGreater thanClose45.900
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Tibet Rhodiola Pharmaceutical Holding Co with someone you think should read this too:
  • Are you bullish or bearish on Tibet Rhodiola Pharmaceutical Holding Co? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Tibet Rhodiola Pharmaceutical Holding Co? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Tibet Rhodiola Pharmaceutical Holding Co

I send you an email if I find something interesting about Tibet Rhodiola Pharmaceutical Holding Co.


Comments

How you think about this?

Leave a comment

Stay informed about Tibet Rhodiola Pharmaceutical Holding Co.

Receive notifications about Tibet Rhodiola Pharmaceutical Holding Co in your mailbox!